Work

Emphysematous Cystitis in an Immunocompetent Patient on an SGLT2 Inhibitor

Year: 2025
Type: article
Study design: Case Report
Abstract: Emphysematous cystitis is a rare, severe infection of the urinary bladder caused by gas-forming organisms like Escherichia coli and Klebsiella pneumoniae (K. pneumoniae). Common risk factors are female sex, chronic urinary infection, immunosuppression, diabetes mellitus, and neurogenic bladder. We report a case of K. pneumoniae emphysematous cystitis in a diabetic male patient being treated with empagliflozin. With this case report, we aim to highlight the potential role of an SGLT-2 inhibitor such as empagliflozin in developing severe urinary infections such as emphysematous cystitis.
Source: Cureus
Authors: Kailey N Nguyen, Dipesh R Bista
Language: English
Subfield: Epidemiology
Field: Medicine
Open Access status: diamond
OpenAlex ID: W4410142307
FWCI: 0.623
Cites: 11
Cited by: 1
Related to: 10